AiCure

IMS Health

Impax to acquire Tower Holdings and Lineage Therapeutics

Wednesday, October 15, 2014 06:00 PM

Hayward, Calif.-based Impax Laboratories will acquire Tower Holdings, including operating subsidiaries CorePharma, based in Middlesex, N.J., Amedra Pharmaceuticals, based in Horsham, Penn., and Lineage Therapeutics, also based in Horsham, for $700 million in cash, subject to certain customary purchase price adjustments.

More... »


IMS Health acquires Cegedim’s CRM and software developer unit

Thursday, June 26, 2014 12:45 PM

IMS Health, which in the last year has been actively making acquisitions leading up to its April IPO, has announced its intention to acquire Paris-based Cegedim’s information solutions and customer relationship management (CRM) business for approximately $520 million in cash.

More... »


IMS Health acquires Forcea

Thursday, May 8, 2014 01:14 PM

IMS Health, a global information and technology services company, has acquired Forcea, a Belgium-based provider of business intelligence applications and analytics for hospitals and life sciences organizations.

More... »

IMS Health files for IPO

Monday, January 6, 2014 03:02 PM

IMS Health, a global information and technology services company, has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.

More... »

Covance launches managed markets services

Friday, August 9, 2013 01:04 PM

Princeton, N.J.-based CRO Covance has created a new service offering focused on providing its biopharmaceutical and medical device clients support to effectively manage contracts in managed markets.

More... »

Greenphire, IMS Health integrate eClinicalGPS and GrantPlan

Wednesday, June 19, 2013 11:49 AM

Greenphire has launched a strategic integration of its eClinicalGPS, a global investigator payment technology, with IMS Health’s GrantPlan, a benchmarking and contracting tool for global clinical site grants.

More... »

IMS Health acquires Incential Software

Monday, June 10, 2013 11:32 AM

IMS Health has acquired Incential Software, a Software-as-a-Service (SaaS) company based in Raleigh, N.C., to advance its sales performance management capabilities for life sciences organizations worldwide. Incential delivers cloud-based technology and services that integrate incentive compensation, data management and business intelligence applications for effective, results-driven sales operations.

More... »

IMS Health advances cloud-based social media analytics with acquisition of Semantelli

Wednesday, May 1, 2013 02:09 PM

IMS Health, a provider of information, services and technology for the healthcare industry, has acquired Semantelli, a Bridgewater, N.J.-based social media analytics company, to extend its marketing and consumer engagement capabilities for healthcare organizations around the world.

More... »

IMS Health acquires TTC, strengthens pharma R&D services capabilities

Friday, August 17, 2012 11:27 AM

IMS Health, a global provider of information, services and technology for the healthcare industry, has acquired TTC, a Philadelphia-based benchmarking solutions and analytics company that helps life sciences organizations around the world plan for and negotiate the costs of clinical trials.

More... »

IMS Health expands suite of syndicated analytics with PharmaDeals acquisition

Wednesday, August 15, 2012 11:22 AM

IMS Health, a provider of information, services and technology for the healthcare industry, has acquired PharmaDeals, a provider of online information about business transactions, licensing, and mergers and acquisitions activity within the global pharmaceutical industry.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs